Abstract:S-nitrosylation (SNO) conveys covalent adduction of nitric oxide (NO)-derived nitrosyl groups to the cysteine thiols of proteins. Estrogen stimulates endothelial cell (EC) nitric oxide (NO) production via endothelial NO synthase (eNOS); however, it is unknown if this also leads to increased formation of SNO-proteins. We hypothesize that estrogen stimulates dynamic nitrosylation via a receptor and endogenous NO dependent pathway in EC. Primary cultured ovine uterine artery and human umbilical cord vein EC were treated with a NO donor nitrosoglutathione (GSNO, 1 mM) or etradiol-17β (E2β, 10 nM) for up to 2h, or E2β with or without L-NAME (2 mM) or ICI 182,780 (1 μM) for 5 min. ECs on glass coverslip were fixed with methanol. SNO-proteins were labeled with biotin in situ by a biotin-switch method as methylmethanethiosulfonate blocking of free thiols, ascorbate reduction and labeling with Texas Red-labeled ethylmethanethiosulfonate. The cells were further co-incubated with either Alex488 labeled Mito-tracker, ConA, or wheat germ agglutinin to track colocalization of SNO-proteins with mitochondria, Golgi complex, or endoplasmic reticulum under a fluorescence microscopy. ECs (~3x106) were lysed and equal amounts of protein extracts (1 mg/group) were similarly biotin-switched, but labeled with biotin-N-(6-(Biotinamido) hexyl)-3'-(2'-pyridyldithio)-propionamide). The profile of total SNO-proteins, which had been labeled with biotin, was determined by immunoblotting with an anti-biotin antibody. Avidin captured biotin-labeled proteins were immunoblotted with specific antibodies to identify SNO-proteins. Basal SNO-proteins were detectable in both EC types in situ. SNO-proteins localized mainly in the mitochondria, less in endoplasmic reticulum, and not at all in Golgi complex. Both GSNO and E2β induced rapid, reversible and time-dependent stimulation of nitrosylation of multiple proteins, which maximized at ~5-10 min. Immunoblotting with specific antibodies identified dynamic nitrosylation of eNOS and its activity regulatory proteins, ERα, HSP90 and caveolin-1, in the avidin captured biotin-labeled proteins. The time courses for E2β-induced nitrosylation of these proteins varied, but maximized within 5-30 min. Pretreatment with the NOS inhibitor L-NAME and the ER antagonist ICI 182,780 for 30 min significantly reduced E2β-induced nitrosylation of eNOS and its regulatory proteins. Thus, we concluded that estrogen stimulates rapid dynamic protein nitrosylation via an estrogen-receptor and endogenous NO-dependent mechanism. S-nitrosylation of eNOS and its regulatory proteins may function as a critical pathway for regulating estrogen stimulation of endothelial cell NO production (Supported by NIH grants HL70562, HL74947, HL49210 and HD38843).

Endothelial NO Synthase-Dependent S-Nitrosylation of Β-Catenin Prevents Its Association with TCF4 and Inhibits Proliferation of Endothelial Cells Stimulated by Wnt3a

Bidirectional cross-regulation between the endothelial nitric oxide synthase and β-catenin signalling pathways.

Enos S-nitrosylation Mediated OxLDL-induced Endothelial Dysfunction Via Increasing the Interaction of Enos with Β‑catenin.

Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

S-nitrosocaptopril Interrupts Adhesion of Cancer Cells to Vascular Endothelium by Suppressing Cell Adhesion Molecules Via Inhibition of the NF-кB and JAK/STAT Signal Pathways in Endothelial Cells

Β -Catenin Activates the Growth Factor Endothelin-1 in Colon Cancer Cells

Molecular control of nitric oxide synthesis through eNOS and caveolin-1 interaction regulates osteogenic differentiation of adipose-derived stem cells by modulation of Wnt/β-catenin signaling

Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma

Modulation Of Beta-Catenin Signaling By The Inhibitors Of Map Kinase, Tyrosine Kinase, And Pi3-Kinase Pathways

Cavin-2 Regulates the Activity and Stability of Endothelial Nitric-Oxide Synthase (enos) in Angiogenesis

Endothelial Nitric Oxide Synthase Regulates Lymphatic Valve Specification by Controlling Β - Catenin Signaling During Embryogenesis

Exogenous, but not Endogenous Nitric Oxide Inhibits Adhesion Molecule Expression in Human Endothelial Cells

Nuclear eNOS interacts with and S-nitrosates ADAR1 to modulate endothelial gene expression

TNF-α-activated eNOS signaling increases leukocyte adhesion through the S-nitrosylation pathway

Lymphocyte-Specific Protein 1 Regulates Expression and Stability of Endothelial Nitric Oxide Synthase

The c-Cbl Ubiquitin Ligase Regulates Nuclear β-Catenin and Angiogenesis by Its Tyrosine Phosphorylation Mediated through the Wnt Signaling Pathway*

Supplementary Figure 1B from Wnt/β-Catenin Signaling Regulates Cytokine-Induced Human Inducible Nitric Oxide Synthase Expression by Inhibiting Nuclear Factor-κB Activation in Cancer Cells

Nitric Oxide Regulates Exocytosis by S-Nitrosylation of N-ethylmaleimide-Sensitive Factor

Estrogen receptor endogenous nitric oxide dependent dynamic S-nitrosylation in estradiol-17 beta-treated endothelial cells

Inhibition of heat shock protein 90 (hsp90) in proliferating endothelial cells uncouples endothelial nitric oxide synthase activity.

Ca2+/Calmodulin-Stimulated Pde1 Regulates the Beta-Catenin/Tcf Signaling Through Pp2a B56 Gamma Subunit in Proliferating Vascular Smooth Muscle Cells